Medical Devices Market
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Asian Neurostimulation/Neuromodulation devices Market The Asian Neurostimulation/Neuromodulation market was expected to reach from $415.32 million in 2013 to $777.62 million by 2018 at a CAGR of 13.4%. The market divided by 2 segments such as Internal Neuromodulation and External Neuromodulation. The internal neuromodulation devices market includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), and external neuromodulation devices such as transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). Major players in the market include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Upcoming |
|
|
European Neurostimulation/Neuromodulation Devices Market The report also provides a detailed competitive landscaping of companies operating in this market. Segment- and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of major companies are detailed in the report. Boston Scientific (U.S.), Cyberonics (U.S), Medtronic, Inc. (U.S.), Depuy Synthes (Johnson & Johnson) (U.S.), and St. Jude Medical Inc. (U.S.) are some of the key players engaged in this market. |
May 2015 |
|
|
North America Internal Neuromodulation Devices Market The North America neuromodulation market has been segmented by procedure, modality, and geography. On the basis of procedure, the market is further segmented into internal and external stimulation. The internal stimulation segment accounted for a share of 87.4% in the neuromodulation market. The market based on modality covers internal and external modality. The internal modality segment accounted for a share of 85.9% in the neuromodulation market. |
May 2015 |
|
|
Special Bundle Secure Payment Link Special Bundle Secure Payment Link |
Upcoming |
|
|
In Vitro Diagnostics The Americas commanded the largest share in the global In Vitro Diagnostics market. Although Europe overall showed a negative growth rate, revenues grew compared to 2011 in some countries. Germany commanded the largest share in European IVD market. Asian IVD market is growing in double digit and will continue to grow in future. China commanded the largest share in Asian IVD market. The report “Global In Vitro Diagnostics Market forecast for 2018 “analyzes the market by 5 segments such as reagents, instruments, techniques, applications and end-users. |
Upcoming |
|
|
PAYMENT LINK _ Drug Discovery Services Market by Process (Target Selection, Hit-to-Lead Identification, Lead Optimization), Type (Medicinal Chemistry, Biology Services, DMPK), Drug Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, Neurology) - Forecast to 2022 PAYMENT LINK _ Drug Discovery Services Market by Process (Target Selection, Hit-to-Lead Identification, Lead Optimization), Type (Medicinal Chemistry, Biology Services, DMPK), Drug Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, Neurology) - Forecast to 2022 |
Upcoming |
|
|
Global Wound Management Market The Global Wound Management market was pegged at $18.6 billion in 2013 and expected to be $26.8 billion by 2018, growing at a CAGR of 7.5%. The report “Wound Management Market forecast, 2012-2018, analyzes the market of Wound care by 4 segments such as traditional, active, advanced, and therapy wound care market. The main companies operating in Wound care market and extensively covered in this report are Kinetic Concepts, Inc. Smith & Nephew plc, 3M healthcare, ConvaTec, Inc., Coloplast and Molnlycke Healthcare. |
Upcoming |
|
|
Ophthalmology devices Opthalmology devices and its peer markets - Dental Devices, Point... |
Upcoming |
|
|
Diabetic Care Devices The market was pegged at $18 billion in 2013 and expected to be $25.3 billion by 2018, growing at a CAGR of 10%. The report “Global Diabetic care Devices Market forecast, 2008-2018 “analyzes the market of devices by 2 main segments such as glucose monitoring devices, and insulin delivery devices. Geographically, the market is mainly segmented into North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) The report also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming |
|
|
Ear, Nose & Throat Devices Ear, Nose & Throat Devices and its peer markets - Physiotherapy Equipments, |
Upcoming |
|
|
Cardiology Devices Cardiology Devices and its peer markets - Medical Aesthetics, |
Upcoming |
|
|
Payment Link - Endoscopy Equipment Market by Product (Endoscope (Flexible, Rigid, Capsule) Visualization Systems, Endoscopic Ultrasound, Insufflator)), Application (GI Endoscopy, Laparoscopy, Cystoscopy, Bronchoscopy, Colonoscopy, Arthroscopy) - Global Forecast to 2022 Payment Link - Endoscopy Equipment Market by Product (Endoscope (Flexible, Rigid, Capsule) Visualization Systems, Endoscopic Ultrasound, Insufflator)), Application (GI Endoscopy, Laparoscopy, Cystoscopy, Bronchoscopy, Colonoscopy, Arthroscopy) - Global Forecast to 2022 |
Upcoming |
|
|
Respiratory & Anesthesia Devices The Global Respiratory & Anesthesia Devices market has gained tremendous importance owing to the widspread acceptance of Home Healthcare Devices. The market is clinched at $12.2 billion in 2013 and is expected to reach a value of $19.5 billion in 2018, with a CAGR of 9.8% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report. |
Upcoming |
|
|
Global Radiotherapy Devices Market The Global Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $5028 million in 2013 and expected to be $5880 million by 2018, growing at a CAGR of 3.2%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as External Beam Radiation Therapy, Internal Beam radiation Therapy, and Systemic radiation Therapy.The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
Apheresis market The global Apheresis market was valued at $1328.81 million in 2013 and is expected to reach $2240.09 million by 2018 growing at a CAGR of 8.5% from 2013 to 2018. Apheresis market can be segmented by By Procedure: Donor Apheresis and Therapeutic Apheresis (Neurologic Disorders, Blood Disorders (TTP, Leukemia, & Others), Renal Disease , Metabolic Disorders, Others (Rheumatic disorders, Malaria, Hyperviscosity syndrome, & others) By Application: (Plasmapheresis, Plateletpheresis Erythrocytapheresis, Leukoreduction/leukapheresis, Others (photopheresis, lipidpheresis, and Immunoadsoption) By Technology: Centrifugation and Membrane Separation/Filtration By Product type: Devices and Disposables By End-user: Blood banks/Blood collection centers, Hospitals & Hospital attached blood banks and Others The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany),& Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack. |
Upcoming |
|
|
Mobility Aid Devices Mobility Aid Devices and its peer markets - Nephrology/Urology Devices, |
Upcoming |
|
|
Feeding Device(Nutrition) Feeding Device(Nutrition) and its peer markets - Diagnostic Imaging, |
Upcoming |
|
|
Medical Simulation Medical Simulation and its peer markets - Drug Delivery Devices, |
Upcoming |
|
|
Payment Link for ATCC - Efficacy Testing Market Report Payment Link for ATCC - Efficacy Testing Market Report |
Upcoming |
|
|
Oral Care Devices The global oral care devices market was valued at $298 million in 2013 and is expected to reach a value of $714.6 million in 2018, with a CAGR of 19.1% from 2013-2018. The market has been segmented on the basis of products, geographies, end users, companies, and macro indicators. Deep dive analysis of the key players have been considered in this report. |
Upcoming |
infertility Treatment
